NPI: 1255387106 · YUBA CITY, CA 95991 · Community Health Clinic/Center · NPI assigned 05/25/2006
Authorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
| Authorized Official | MOTSIFF, TOM (CFO) |
| NPI Enumeration Date | 05/25/2006 |
Other providers sharing the same authorized official: MOTSIFF, TOM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,243 | $428K |
| 2019 | 4,931 | $220K |
| 2020 | 3,799 | $183K |
| 2021 | 7,283 | $432K |
| 2022 | 8,442 | $508K |
| 2023 | 14,118 | $887K |
| 2024 | 11,843 | $575K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J3490 | Unclassified drugs | 8,378 | 6,776 | $423K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,042 | 3,936 | $382K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 655 | 655 | $329K |
| S4993 | Contraceptive pills for birth control | 2,155 | 2,100 | $274K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,933 | 1,925 | $230K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 195 | 195 | $226K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,342 | 3,233 | $203K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,088 | 1,062 | $154K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 765 | 762 | $149K |
| 87806 | 5,393 | 4,747 | $136K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,779 | 2,712 | $95K |
| A4267 | Contraceptive supply, condom, male, each | 3,539 | 3,522 | $92K |
| 99201 | 593 | 589 | $59K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,853 | 1,837 | $55K |
| 11981 | 181 | 181 | $50K | |
| 58300 | 321 | 164 | $44K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,324 | 1,315 | $41K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,314 | 1,305 | $40K |
| S0190 | Mifepristone, oral, 200 mg | 619 | 618 | $36K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 153 | 153 | $35K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 388 | 377 | $22K |
| J7304 | Contraceptive supply, hormone containing patch, each | 27 | 27 | $22K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 1,604 | 1,604 | $20K |
| 99401 | 1,021 | 994 | $19K | |
| 81025 | 4,141 | 4,082 | $15K | |
| 99000 | 3,953 | 3,853 | $12K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 706 | 452 | $10K |
| 99402 | 279 | 276 | $9K | |
| S5000 | Prescription drug, generic | 1,098 | 959 | $9K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 91 | 91 | $7K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 1,754 | 1,703 | $7K |
| 83986 | 2,118 | 1,918 | $6K | |
| 11982 | 76 | 38 | $5K | |
| 58301 | 103 | 52 | $4K | |
| 85018 | 212 | 204 | $2K | |
| S0191 | Misoprostol, oral, 200 mcg | 694 | 676 | $2K |
| 11976 | 24 | 12 | $1K | |
| 99403 | 29 | 29 | $1K | |
| Q3014 | Telehealth originating site facility fee | 53 | 51 | $1K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 226 | 198 | $716.51 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 59 | 58 | $695.78 |
| 81002 | 287 | 280 | $594.79 | |
| J4390 | 31 | 12 | $220.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 13 | 13 | $75.06 |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 50 | 50 | $67.92 |